Cambridge Bioscience is delighted to announce an expanded strategic distribution partnership with Salimetrics, following our recent acquisition of Stratech Scientific. This strengthens access to Salimetrics’ industry-leading salivary bioscience and dried blood spot (DBS) research solutions for life science, academic, clinical research and diagnostic researchers across the UK and Ireland.
The partnership will provide scientists with streamlined access to Salimetrics’ extensive portfolio of products and services, including salivary immunoassay kits, saliva and DBS sample collection devices, biomarker testing services, and specialised laboratory solutions designed to support research in stress, behaviour, inflammation, immune function, metabolomics, infectious disease and broader biobehavioural sciences.
Salimetrics is a recognised leader in salivary bioscience and biomarker research. The company provides FDA-registered, ISO 13485:2016-certified, cGMP-compliant and CE-marked solutions that support researchers, academic institutions, pharmaceutical companies and contract research organisations worldwide. Salimetrics is also known for its expertise in saliva- and DBS-based sample collection, assay development, laboratory testing and CLIA-certified biomarker analysis services.
Through this partnership, Cambridge Bioscience will provide local technical support, product expertise and customer service, ensuring researchers across the UK and Ireland can fully leverage Salimetrics’ trusted portfolio, innovative collection technologies and laboratory capabilities to advance their scientific discoveries.
This collaboration further strengthens Cambridge Bioscience’s commitment to supporting the UK and Ireland life science community with high-quality tools and technologies that accelerate research, innovation and discovery. By bringing together Cambridge Bioscience’s regional expertise and Salimetrics’ leadership in saliva- and DBS-based bioscience, researchers will benefit from easier access to validated solutions that deliver reliable and reproducible biomarker data.
Learn more about Salimetrics’ portfolio or contact our Salimetrics specialists.